Guidelines for cellular and molecular pathology content in clinical trial protocols: the SPIRIT-Path extension. (2021)

First Author: Kendall TJ
Attributed to:  MICA: The Newcastle Proximity Laboratory funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s1470-2045(21)00344-2

PubMed Identifier: 34592193

Publication URI: http://europepmc.org/abstract/MED/34592193

Type: Journal Article/Review

Volume: 22

Parent Publication: The Lancet. Oncology

Issue: 10

ISSN: 1470-2045